ADVERTISEMENT
Dr. Jildaz Caroff
Interventional Neuroradiologist
Bicêtre Hospital
Paris, France
Thrombectomy has emerged as a transformative treatment approach for acute ischemic stroke, offering new hope for patients and significantly improving outcomes. [...]
In this final newsletter, we delve into the critical need for evidence-based clinical management of tough clots, emphasizing the importance of refining treatment strategies and comparing techniques to optimize patient outcomes.
Tune in to Dr. Adnan Siddiqui's interview for expert point of view on the importance of prospective registries, gaps in evidence, key findings from Arise II registry, objectives of the Excellent registry, and the barriers preventing physicians from following evidence-based BGC use.
Dive into the SPERO study as Dr. Marc Ribó unveils its design, results, clot histology, and his visionary outlook on future advancements in pre-intervention clot characterization. In the meantime, explore his expert advice for managing tough clots and check how efficient is the Nimbus™ stent retriever as an innovative strategy for tough clots.
While it is established that stent-retriever thrombectomy yields better results in patients with acute ischemic stroke when compared to medical management, there is still a lack of investigation into the variations among different types of stent-retrievers. The MASTRO meta-analysis aimed to compare outcomes between three stent-retrievers.
Supported by
